Literature DB >> 26901651

Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review.

Sharareh Eskandarieh1, Pouria Heydarpour, Alireza Minagar, Shadi Pourmand, Mohammad Ali Sahraian.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is one of the most common chronic immune-mediated diseases of the human central nervous system and an important cause of non-traumatic neurologic disability among young population in several countries. Recent reports from East Asia, South East Asia and South Asia have proposed a low to moderate prevalence of MS in these countries.
METHODS: A literature review search was carried out in December 2014 in Medline, Embase, Scopus and Cochrane library to recover original population-based studies on MS epidemiology in East Asia, South East Asia and South Asia countries published between January 1, 1950 and December 30, 2014. We intended search strategies using the key words: multiple sclerosis, prevalence, incidence and epidemiology. Based on our inclusion criteria, 68 epidemiologic studies were included in this systematic review.
RESULTS: The most extensively used diagnostic criteria in the studies were McDonald's criteria. Most studies were performed in a multi-center hospital setting. The female to male ratio varied and ranged from 0.7 in India to 9.0 in China. The mean age at disease onset ranged from the lowest age of 25.3 in Iran to the highest age of 46.4 in China. MS prevalence ranged from 0.77 in 100,000 populations in Hong Kong (1999) to 85.80 in 100,000 in Iran (2013).
CONCLUSIONS: Advances in MS registries around the globe allow nationwide population-based studies and will allow worldly comparisons between the prevalence and incidence in different regions that are provided to monitor estimation.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26901651     DOI: 10.1159/000444019

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  28 in total

1.  Down-regulation of ERMN expression in relapsing remitting multiple sclerosis.

Authors:  Behnaz Salek Esfahani; Jalal Gharesouran; Soudeh Ghafouri-Fard; Shahrzad Talebian; Shahram Arsang-Jang; Mir Davood Omrani; Mohammad Taheri; Maryam Rezazadeh
Journal:  Metab Brain Dis       Date:  2019-05-23       Impact factor: 3.584

Review 2.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

Review 3.  The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years.

Authors:  Sergio E Baranzini; Jorge R Oksenberg
Journal:  Trends Genet       Date:  2017-10-05       Impact factor: 11.639

4.  Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Jalal Dahham; Rana Rizk; Ingrid Kremer; Silvia M A A Evers; Mickaël Hiligsmann
Journal:  Pharmacoeconomics       Date:  2021-05-06       Impact factor: 4.981

5.  Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Neurol       Date:  2017-09-17       Impact factor: 44.182

6.  Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka.

Authors:  S M K Gamage; I Wijeweera; S B Adikari; Katharina Fink; Jan Hillert; Anna Fogdell-Hahn; H M A Sominanda
Journal:  Mult Scler Int       Date:  2018-02-28

7.  Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Authors:  Zhifeng Mao; César Álvarez-Gonzalez; Stefania De Trane; Ozlem Yildiz; Christo Albor; Gabriel Doctor; Derek Soon; George Pepper; Benjamin P Turner; Monica Marta; Joela Mathews; Gavin Giovannoni; David Baker; Klaus Schmierer
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-06-26

8.  Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.

Authors:  Sharareh Eskandarieh; Narges Sistany Allahabadi; Malihe Sadeghi; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2018-02-07       Impact factor: 2.474

9.  Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease.

Authors:  Wing L Cheong; Devi Mohan; Narelle Warren; Daniel D Reidpath
Journal:  Front Neurol       Date:  2018-06-08       Impact factor: 4.003

10.  Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up.

Authors:  Riwanti Estiasari; Adisresti Diwyacitta; Muhammad Sidik; Ni Nengah Rida Ariarini; Freddy Sitorus; Saraf Shafa Marwadhani; Kartika Maharani; Darma Imran; Reza Aditya Arpandy; David Pangeran; Manfaluthy Hakim
Journal:  Neurol Res Int       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.